JOSHUA ODERANTI: Open Payments
NPI 1114441102 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 17 payments from 11 companies in 2025. Trend: 2023 $317 · 2024 $660 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $419 |
| GlaxoSmithKline, LLC. | 2 | $245 |
| Pharmacosmos Therapeutics Inc. | 2 | $241 |
| E.R. Squibb & Sons, L.L.C. | 2 | $125 |
| Geron Corporation | 1 | $114 |
| Lilly USA, LLC | 1 | $81 |
| Genentech USA, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: RYBREVANT, MONOFERRIC, DARZALEX, NUCALA, JEMPERLI, RYTELO, REBLOZYL, OPDIVO.
Industry payments across NJ — which companies pay providers there.
